
<!-- saved from url=(0064)file:///C:/Users/ygowda/Desktop/output/18836203/18836203_21.html -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252"></head><body><table border="1">
<tbody><tr><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Quarter ended</span></p></td><td>
<p></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Year ended</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">SI.</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Particulars</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">31.03.2018</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">31.12.2017</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">31.03.2017</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">31.03.2018</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">31.03.2017</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">No.</span></p></td><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">(Audited)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">(Unaudited)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">(Audited)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">(Audited)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">(Audited)</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font1">1</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Segment wise revenue and results<br>Segment revenue</span></p>
<p><span class="font2">a) Pharmaceutical Services and Active Ingredients</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">6,268</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">5,605</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">5,786</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">22,741</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">22,564</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">b) Global Generics</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">20,068</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">20,929</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">18,814</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">76,150</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">80,277</span></p></td></tr>
<tr><td>
<p></p></td><td>
<p><span class="font2">c) Proprietary Products</span></p></td><td>
<p><span class="font2">27</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">26</span></p></td><td>
<p><span class="font2">417</span></p></td><td>
<p><span class="font2">109</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">417</span></p></td></tr>
<tr><td>
<p></p></td><td>
<p><span class="font1" style="font-weight:bold;">Total</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">26,363</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">26,560</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">25,017</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">99,000</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">103,258</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">Less: Inter-segment revenue</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,440</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,330</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,422</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">5,407</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">6,066</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font2">Add: Other un-allocable income</span></p></td><td>
<p></p></td><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">6</span></p></td><td style="vertical-align:middle;">
<p><span class="font2">-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">6</span></p></td></tr>
<tr><td>
<p></p></td><td>
<p><span class="font1" style="font-weight:bold;">Total revenue from operations</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">24,923</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">25,230</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">23,601</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">93,593</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">97,198</span></p></td></tr>
<tr><td>
<p><span class="font1" style="font-weight:bold;">2</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Segment results</span></p>
<p><span class="font2">Profit / (loss) before tax and interest from each segment<br>a) Pharmaceutical Services and Active Ingredients</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">383</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">56</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(598)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(3)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(1,446)</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">b) Global Generics</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,482</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,828</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,795</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">11,956</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">17,817</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">c) Proprietary Products</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(841)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(701)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(679)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(3,464)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(3,124)</span></p></td></tr>
<tr><td>
<p></p></td><td>
<p><span class="font1" style="font-weight:bold;">Total</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">3,024</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">3,183</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">518</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">8,489</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">13,247</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">Less: (i) Finance costs</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">140</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">133</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">158</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">628</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">572</span></p></td></tr>
<tr><td>
<p></p></td><td>
<p><span class="font2">(ii) Other un-allocable expenditure / (income), net</span></p></td><td>
<p><span class="font2">929</span></p></td><td>
<p><span class="font2">(666)</span></p></td><td>
<p><span class="font2">(1,274)</span></p></td><td>
<p><span class="font2">891</span></p></td><td>
<p><span class="font2">(2,770)</span></p></td></tr>
<tr><td>
<p></p></td><td>
<p><span class="font1" style="font-weight:bold;">Total profit before tax</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">1,955</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">3,716</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">1,634</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">6,970</span></p></td><td>
<p><span class="font1" style="font-weight:bold;">15,445</span></p></td></tr>
</tbody></table></body></html>